cp wire

CP Wire Articles

Satsuma Pharmaceuticals Files for $80 Million IPO

Satsuma Pharmaceuticals file the paperwork for an $80 million IPO on 9/11/19. The company is developing a nasal delivery form of dihydroergotamine mesylate (DHE) for treating migraine headaches.... read more

Thu, 09/12/19 - 09:33 am
Microbiome Report

Azitra, Inc.Appoints Mark Sampson, Ph.D. as Chief Scientific Officer
On 8/27/19, Azitra, Inc., a clinical-stage medical dermatology company addressing severe skin conditions by... read more

Wed, 09/11/19 - 10:42 pm
Monopar raises IPO Target to $46 Million

Monopar filed an amendment to its IPO filing on 9/10/19. It has raised its upper estimate to $46 Million. The company will trade on NASDAQ under the symbol, “MNPR.” See original... read more

Wed, 09/11/19 - 09:34 am
[release] Vascular Therapies Announces Positive Preliminary Clinical Results from its AV Fistula Trials in Patients with Kidney Disease
CRESSKILL, N.J., September 5, 2019 /PRNewswire/ -- Vascular Therapies, a clinical stage biotechnology company, is developing Sirogen™, a proprietary sirolimus formulation for intraoperative... read more
Tue, 09/10/19 - 09:37 am
Plus Therapeutics Files for $34 Million Offering

On 9/10/19, Plus Therapeutics filed for a $34 million offering that will consist of Class A units, Class B units, common stock and warrants to purchase common stock. Plus is developing oncology... read more

Tue, 09/10/19 - 09:29 am

Pages